Tirzepatide

Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This unique mechanism of action has made it an exciting compound for research into metabolic disorders, particularly type 2 diabetes, obesity, and related metabolic conditions. By simultaneously targeting two key incretin pathways, tirzepatide offers novel potential for improving glycemic control, promoting weight loss, and regulating metabolic health.